We appreciate your patience. Your content is on the way.
SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Jagsonpal Pharmaceuticals Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India. It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company. The Company`s R&D activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. It`s R&D activities are geared towards development of new product technologies which can be commercialised in future. It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia. In the fiscal 2001, the company`s sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity. The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021. On June 27, 2022, Infinity Holdings, an India-focused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals` confidence and improve patient outcomes in 2023-24. It acquired the India and Bhutan business of Yash Pharma in May, 2024.
Jagsonpal Pharmaceuticals share price as on 13 Jun 2025 is Rs. 235.02. Over the past 6 months, the Jagsonpal Pharmaceuticals share price has decreased by 13.39% and in the last one year, it has increased by 75.55%. The 52-week low for Jagsonpal Pharmaceuticals share price was Rs. 130.48 and 52-week high was Rs. 328.04.
507789
JAGSNPHARM
INE048B01035
Sep
Jagsonpal Pharmaceuticals Ltd FAQs
You can buy Jagsonpal Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jagsonpal Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 12, 2025 03:42 PM the closing price of Jagsonpal Pharmaceuticals Ltd was Rs.235.02.
The latest PE ratio of Jagsonpal Pharmaceuticals Ltd as of Jun 12, 2025 03:42 PM is 39.23
The latest PB ratio of Jagsonpal Pharmaceuticals Ltd as of Jun 12, 2025 03:42 PM is 0.15
The 52-week high of Jagsonpal Pharmaceuticals Ltd share price is Rs. 328.04 while the 52-week low is Rs. 130.48
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 12, 2025 03:42 PM, the market cap of Jagsonpal Pharmaceuticals Ltd stood at Rs. 1,560.51 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.